Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
出版年份 2022 全文链接
标题
Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 20, Pages 12481
出版商
MDPI AG
发表日期
2022-10-19
DOI
10.3390/ijms232012481
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients
- (2022) Jie Liu et al. Clinics and Research in Hepatology and Gastroenterology
- Banting memorial lecture 2022: ‘Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime’
- (2022) Christopher D. Byrne DIABETIC MEDICINE
- Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2022) Melanie J. Davies et al. DIABETES CARE
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
- (2022) Kiarash Riazi et al. Lancet Gastroenterology & Hepatology
- Management of non-alcoholic fatty liver disease
- (2021) Maria Letizia Petroni et al. BMJ-British Medical Journal
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
- (2021) Anastasia‐Stefania Alexopoulos et al. HEPATOLOGY
- A call to action for fatty liver disease
- (2021) Alessandro Mantovani et al. LIVER INTERNATIONAL
- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
- (2021) Giovanni Targher et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
- (2021) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study
- (2021) Susan Sam et al. DIABETES CARE
- Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed
- (2021) Christopher D Byrne et al. GUT
- Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
- (2021) Diego García-Compeán et al. Annals of Hepatology
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals
- (2020) Bin Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
- (2020) Alessandro Mantovani et al. Metabolites
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
- (2019) Andrew P. McGovern et al. BMC Medicine
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
- (2019) A. Mantovani et al. DIABETES & METABOLISM
- Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control
- (2018) Preya Janubhai Patel et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients
- (2018) Babalola Ishmael Afolabi et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
- (2018) Frédéric Brioude et al. Nature Reviews Endocrinology
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes
- (2018) A. Mantovani et al. DIABETES & METABOLISM
- Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease
- (2018) Kenichi Tanaka et al. HEPATOLOGY RESEARCH
- NAFLD and diabetes mellitus
- (2016) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
- (2013) Giovanni Targher et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology
- (2010) Samer Gawrieh et al. Annals of Diagnostic Pathology
- Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis
- (2009) E. Hamaguchi et al. DIABETES CARE
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
- (2009) Vincent Wai-Sun Wong et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started